Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Dynamic Biotechnology & Genome Invesco ETF (PBE)

Dynamic Biotechnology & Genome Invesco ETF (PBE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Overview

Name Invesco Dynamic Biotechnology & Genome ETF
Fund Family Invesco
Underlying Index Dynamic Biotechnology & Genome Intellidex Index
Inception Date 06/23/05
First Trade Date 06/23/05
Leverage Long
Asset Class Equity

Description:

The Invesco Dynamic Biotechnology and Genome ETF is based on the Dynamic Biotech and Genome Intellidex Index. The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Intellidex Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including price momentum, earnings momentum, quality, management action, and value. The Underlying Intellidex Index is comprised of common stocks of 30 US biotechnology and genome companies. These are companies that are principally engaged in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes and companies that benefit significantly from scientific and technological advances in biotechnology and genetic engineering and research. The Fund and the Index are rebalanced and reconstituted quarterly in February, May, August and November.

Investment Information

Alpha -4.45
60-Month Beta 0.94
Standard Deviation -1.02
Shares Outstanding, K 3,990.00
Managed Assets, $K 265,809.40 K
Net Asset Value 66.62
First Trade Price 14.89
P/E Ratio 25.59
Management Fee 0.59%
Options Yes
Latest Dividend 0.029
Dividend Date 03/23/20
Annual Dividend 0.00
Annual Dividend Yield 0.00%
1-Year Return -14.65%
3-Year Return 27.22%
5-Year Return 44.70%
Management Expense Ratio 0.59%

PBE Dividends

Date Value
03/23/20 $0.0290
09/24/18 $0.0020
06/16/17 $0.2150
03/17/17 $0.0560
12/16/16 $0.1210
09/16/16 $0.0280
12/18/15 $0.3080
09/18/15 $0.1365
06/19/15 $0.1227
09/19/14 $0.0429
06/20/14 $0.2340
12/18/09 $0.0760
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar